Epostane (CAS 80471-63-2) Suppliers and Product Information

Epostane is a 3β-Hydroxysteroid dehydrogenase inhibitor and a derivative of trilostane. It has been developed as a contraceptive, abortifacient, and oxytocic drug, though it was never marketed. Epostane functions by inhibiting 3β-HSD, which blocks the biosynthesis of progesterone from pregnenolone, thereby acting as an antiprogestogen and terminating pregnancy.

Frequently Asked Questions about Epostane

Q: What is the primary use of Epostane?

A: Epostane is primarily used in laboratory research to explore the biological impacts of steroid hormones. It has been investigated for its potential as a contraceptive, abortifacient, and oxytocic drug, though it was never marketed for these purposes.

Q: How does Epostane work?

A: Epostane works by inhibiting 3β-hydroxysteroid dehydrogenase (3β-HSD), which blocks the biosynthesis of progesterone from pregnenolone. This action makes it function as an antiprogestogen, potentially terminating pregnancy.

Q: Is Epostane approved for human use?

A: No, Epostane was developed but never marketed for human use. It is primarily used in scientific research to study the effects of androgens on various biological systems.

Q: What are some areas of research where Epostane is used?

A: Epostane has been used in scientific investigations examining the effects of androgens on male reproductive organ development and function, brain development and function, cardiovascular system, immune system, and endocrine system.